Product Information
INDAPAMIDE 1.25 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1067 per EA under NDC 16571087501. Its NADAC has been published 155 times since Sep 6, 2023.
FDA first approved this application on Mar 27, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1.25 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571087501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
INDAPAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074461FDA Approved
3/27/1996
TE Code
AB
On Market Since
6/22/2023
Pharmacological Classes
Price Statistics
The NADAC for INDAPAMIDE 1.25 MG TABLET has been published 155 times since Sep 6, 2023, and over the history we have for it it has declined 10.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1067 per EA |
|---|---|
| All-time high | $0.1243 (Apr 10, 2024) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1091 |
| 52-week low | $0.0993 |
| Median price | $0.1058 |
| Average price | $0.1069 |
| Largest weekly change | -29.9% (Nov 20, 2024) |
| Weeks tracked | 155 |
| Tracking since | Sep 6, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INDAPAMIDE 1.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for INDAPAMIDE 1.25 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1067 per EA (NDC 16571087501), effective Aug 19, 2026.
How has the price of INDAPAMIDE 1.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for INDAPAMIDE 1.25 MG TABLET has declined 10.0%. It has been tracked across 155 weekly CMS publications since Sep 6, 2023.
What are the highest and lowest recorded NADAC prices for INDAPAMIDE 1.25 MG TABLET?
Since Sep 6, 2023, the NADAC for INDAPAMIDE 1.25 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.1243 (Apr 10, 2024), with a median of $0.1058 per EA.
Are there cheaper alternatives to INDAPAMIDE 1.25 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as INDAPAMIDE 1.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures INDAPAMIDE 1.25 MG TABLET?
INDAPAMIDE 1.25 MG TABLET (NDC 16571087501) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.